| William Joseph Schmitt, DO | |
|
1600 1st St E, Independence, IA 50644-3155 | |
| (319) 332-0999 | |
| Not Available |
| Full Name | William Joseph Schmitt |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 1600 1st St E, Independence, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053792887 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 04396 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cedar Valley Hospice | Waterloo, IA | Hospice |
| Buchanan County Health Center | Independence, IA | Hospital |
| Abcm Rehab Centers Of Independence West Campus | Independence, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peoples Memorial Hospital | 9931010790 | 41 |
News Archive
Preterm birth - birth before 37 weeks of pregnancy - affects up to one in every six births in the United States and many other countries.
University of Toronto researchers examined data on patients who had been hospitalized in the United States for subarachnoid hemorrhage (SAH) and found racial/ethnic differences in the rates of inpatient mortality and hospital discharge to institutional care.
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
Scientists investigating how certain genes affect an individual's risk of developing coronary heart disease have identified a new therapeutic target, according to research published today in The American Journal of Human Genetics.
› Verified 6 days ago
| Entity Name | Peoples Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336281245 PECOS PAC ID: 9931010790 Enrollment ID: O20031118000161 |
News Archive
Preterm birth - birth before 37 weeks of pregnancy - affects up to one in every six births in the United States and many other countries.
University of Toronto researchers examined data on patients who had been hospitalized in the United States for subarachnoid hemorrhage (SAH) and found racial/ethnic differences in the rates of inpatient mortality and hospital discharge to institutional care.
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
Scientists investigating how certain genes affect an individual's risk of developing coronary heart disease have identified a new therapeutic target, according to research published today in The American Journal of Human Genetics.
› Verified 6 days ago
| Entity Name | Broadlawns Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467447508 PECOS PAC ID: 3678466166 Enrollment ID: O20040206000913 |
News Archive
Preterm birth - birth before 37 weeks of pregnancy - affects up to one in every six births in the United States and many other countries.
University of Toronto researchers examined data on patients who had been hospitalized in the United States for subarachnoid hemorrhage (SAH) and found racial/ethnic differences in the rates of inpatient mortality and hospital discharge to institutional care.
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
Scientists investigating how certain genes affect an individual's risk of developing coronary heart disease have identified a new therapeutic target, according to research published today in The American Journal of Human Genetics.
› Verified 6 days ago
| Entity Name | Peoples Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518417518 PECOS PAC ID: 9931010790 Enrollment ID: O20161117001041 |
News Archive
Preterm birth - birth before 37 weeks of pregnancy - affects up to one in every six births in the United States and many other countries.
University of Toronto researchers examined data on patients who had been hospitalized in the United States for subarachnoid hemorrhage (SAH) and found racial/ethnic differences in the rates of inpatient mortality and hospital discharge to institutional care.
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
Scientists investigating how certain genes affect an individual's risk of developing coronary heart disease have identified a new therapeutic target, according to research published today in The American Journal of Human Genetics.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Joseph Schmitt, DO 1600 1st St E, Independence, IA 50644-3155 Ph: (319) 332-0999 | William Joseph Schmitt, DO 1600 1st St E, Independence, IA 50644-3155 Ph: (319) 332-0999 |
News Archive
Preterm birth - birth before 37 weeks of pregnancy - affects up to one in every six births in the United States and many other countries.
University of Toronto researchers examined data on patients who had been hospitalized in the United States for subarachnoid hemorrhage (SAH) and found racial/ethnic differences in the rates of inpatient mortality and hospital discharge to institutional care.
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
Scientists investigating how certain genes affect an individual's risk of developing coronary heart disease have identified a new therapeutic target, according to research published today in The American Journal of Human Genetics.
› Verified 6 days ago
Kurt Anthony House, D.O.,F.P. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 1st St E, Independence, IA 50644 Phone: 319-334-2541 Fax: 319-334-7054 | |
Duane Donald Jasper, MD FP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 1st St E, Independence, IA 50644 Phone: 319-334-2541 Fax: 319-334-7054 | |
Dr. Ricky R Mccormick, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 1st St E, Independence, IA 50644 Phone: 319-334-2541 Fax: 319-334-7054 | |
David Lawrence Fahey, D.O.. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 1st St E, Independence, IA 50644 Phone: 319-332-0999 |